IL-15 Serum Concentrations and CD19 CAR T-Cell Therapy: Impact on Clinical Outcomes and In Vivo CAR T Cell Kinetics
Jordan Gauthier(Seattle Cancer Care Alliance), Cameron J. Turtle(The University of Sydney), David G. Maloney(Fred Hutch Cancer Center), Delaney R. Kirchmeier(Fred Hutch Cancer Center), Henna A Di(Fred Hutch Cancer Center), Qian Wu(Cancer Research Center), Cassie Chou(University of Washington), Alexandre V. Hirayama(University of Washington), Salvatore Fiorenza, Jenna Voutsinas(Fred Hutch Cancer Center), Abby W Jamieson, Stanley R. Riddell(Fred Hutch Cancer Center), Tinh-Doan Phi, Barbara S. Pender, Erik L. Kimble(University of Washington)
Cited by 0
Related Papers
ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector Cells
|Transplantation and Cellular Therapy|2018|3.6k
Reconstitution of Cellular Immunity against Cytomegalovirus in Recipients of Allogeneic Bone Marrow by Transfer of T-Cell Clones from the Donor
|New England Journal of Medicine|1995|1.8k